Combining virtual reality and hypnosis to alleviate chronic pain in elderly with hand arthritis: protocol for a randomised phase II clinical trial

Valentyn Fournier, M. Simard, Sai Yan Yuen, Joséphine Guiné, Floriane Rousseaux, Julie Lebeau, Karim Jerbi, Philippe Richebé, Mathieu Landry, Pierre Rainville, David OgezBMJ 2025 · DOI

TL;DR

This paper outlines a protocol for a Phase II randomized controlled trial investigating the effectiveness of combining virtual reality (VR) and hypnosis (VRH) to alleviate chronic pain in elderly individuals with hand arthritis. The study aims to address the limitations of current pain management strategies by exploring a non-pharmacological, potentially more accessible therapeutic approach.

What Problem Does This Paper Address?

Chronic pain is a widespread and debilitating condition, particularly prevalent in the aging population. Current management often relies on pharmacological interventions like opioids, which carry significant risks of addiction, overdose, and other adverse effects. Non-pharmacological approaches, such as hypnosis and VR, have shown promise individually, but their combined efficacy, especially in a rigorous clinical trial setting for a specific population like elderly individuals with hand arthritis, remains underexplored. This study aims to fill this gap by evaluating a novel VRH intervention, addressing the need for effective, safe, and accessible pain management solutions.

Methods

This study employs a single-center, randomized controlled trial (RCT) design. Participants will be randomly assigned to either an experimental group receiving the VRH intervention or a control group receiving only VR. The intervention involves using a VR headset with an integrated audio system, delivering hypnotic inductions and analgesic suggestions through a personalized VR software.

Key methodological aspects include:

  • VRH Intervention: The experimental group will receive hypnosis techniques, including a "magic hand" intervention (learning to apply analgesia with their hand) and a pain manipulation intervention, all delivered within a VR environment. The control group will experience a simplified VR environment without the hypnotic components.
  • Standardized Procedure: A detailed protocol is established, including specific session timings, content, and counterbalancing procedures to minimize bias.
  • Blinding and Allocation Concealment: While participants and interventionists cannot be blinded due to the nature of the intervention, data analysts will be blinded to group allocation to reduce bias in statistical analysis. Neutral information will be provided to participants to mitigate expectancy bias.
  • Outcome Measures:
    • Primary Outcome: Perceived pain intensity, measured by the Brief Pain Inventory-Short Form (BPI-SF).
  • Secondary Outcomes: Anxiety and depressive symptoms (Hospital Anxiety and Depression Scale - HADS), quality of life (SF-12), and fatigue (Multidimensional Fatigue Inventory-10 Items).
  • Exploratory Outcomes: Physiological variables (heart rate variability, respiratory rate, electrodermal activity), medication consumption, and perceived changes in symptoms.
  • Power Analysis: An a priori power analysis was conducted, determining a sample size of 82 participants, with an anticipated 20% attrition rate leading to a recruitment target of 98 participants.

Datasets

Not discussed in the paper. The study focuses on a clinical trial protocol and does not involve pre-existing datasets for training or evaluation.

Key Insights and Ideas

  • Synergistic Potential of VR and Hypnosis: The core idea is that combining VR and hypnosis could offer a more potent pain management strategy than either modality alone, potentially by targeting both focused and peripheral attention more effectively.
  • Addressing Hypnosis Limitations: VRH is proposed to overcome practical limitations of traditional hypnosis, such as therapist availability, time commitment, and the cognitive effort required from patients.
  • Patient-Centered Design: The study protocol was developed with significant input from patients with chronic pain, ensuring the intervention is clinically relevant and addresses real-world needs.
  • Comprehensive Outcome Measurement: The inclusion of both subjective (pain scores, quality of life) and objective (physiological measures) outcomes provides a more holistic understanding of the intervention's impact.
  • Focus on Elderly Hand Arthritis: Targeting this specific demographic and condition is crucial, as the aging population is disproportionately affected by chronic pain, and hand arthritis significantly impacts daily functioning.

Key Results

As this is a protocol paper, no results from the trial are presented. The paper outlines the planned methodology and expected outcomes.

Limitations and Future Work

Limitations:

  • Floor Effect Risk: The authors acknowledge a potential risk of a "floor effect" where outcomes might be too low to detect significant differences, especially given that both groups will receive VR.
  • Lack of Placebo Condition: A true placebo VR intervention is considered unavailable, which could limit the ability to fully disentangle the effects of VR itself from the VRH intervention.
  • Blinding Challenges: Due to the nature of the intervention, participants and interventionists cannot be blinded.

Future Work:

  • Phase III Trial: This Phase II study is designed to pave the way for a larger-scale Phase III RCT, investigating the long-term effects of VRH and its applicability to other chronic pain conditions.
  • Refinement of Intervention: The findings from this study will inform potential adjustments to the VRH intervention for future implementation.
  • Broader Accessibility: The study aims to contribute to the development of accessible, non-pharmacological pain management solutions that could be implemented in various healthcare settings and potentially at home.

Summary updated

Abstract

NCT06833905.
BibTeX
@inproceedings{fournier2025combining,
  author = {Valentyn Fournier and M. Simard and Sai Yan Yuen and Joséphine Guiné and Floriane Rousseaux and Julie Lebeau and Karim Jerbi and Philippe Richebé and Mathieu Landry and Pierre Rainville and David Ogez},
  title = {{Combining virtual reality and hypnosis to alleviate chronic pain in elderly with hand arthritis: protocol for a randomised phase II clinical trial}},
  booktitle = {BMJ},
  year = {2025},
  doi = {10.1136/bmjopen-2025-103841},
}
Figure